---
title: "IFM Therapeutics"
#date: '`r paste("Date:",Sys.Date())`'
fontsize: 12pt
output: html_document
---

<style type="text/css">

body{ /* Normal  */
      font-size: 13px;
  }
}
h1.title {
  font-size: 28px;
  color: DarkBlue;
}
h1 { /* Header 1 */
  font-size: 20px;
  color: DarkBlue;
}
h2 { /* Header 2 */
    font-size: 16px;
  color: DarkBlue;
}

}
code.r{ /* Code block */
    font-size: 12px;
}
pre { /* Code block - determines code spacing between lines */
    font-size: 14px;
}
</style>

\



#**IFM Therapeutics (potential competitive strength):  **  
Antagonists of the cGAS-STING Pathway:   
The molecules that IFM is developing to block the cGAS/STING pathway will be useful to treat diseases that result from abnormal signals induced by cytosolic DNA, including both rare autoinflammatory and autoimmune diseases like Aicardi-Gouti√®res syndrome and more common conditions such as systemic lupus erythematosus, in which excessive type interferon signaling drives disease. 


#**Pipeline**  

<img src="timeline_pic.png" style="width:50%; height:70px">
<img src="./company_analysis_excel/ifm.jpg">





For more details, check the reference below.




# Reference     
https://www.ifmthera.com/pipeline/




